AMANDA TYRA: Open Payments
NPI 1013508167 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,049 in 20 payments from 10 companies in 2025. Trend: 2023 $236 · 2024 $897 · 2025 $2,049
Food & beverage: $1,103Travel & lodging: $947
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 4 | $1,223 |
| ABBVIE INC. | 4 | $265 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $140 |
| Phathom Pharmaceuticals, Inc. | 2 | $123 |
| Janssen Scientific Affairs, LLC | 1 | $108 |
| Janssen Biotech, Inc. | 3 | $53 |
| QOL Medical, LLC | 1 | $41 |
| Madrigal Pharmaceuticals | 1 | $39 |
| Gilead Sciences, Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $28 |
Products named: TREMFYA, XIFAXAN, VOQUEZNA, RINVOQ, Sucraid, REZDIFFRA, SKYRIZI, Livdelzi.
Industry payments across GA — which companies pay providers there.
